-
Health-Related Quality of Life Measured by EQ-5D Utility Among Patients With TGCT: A Trial-Based Analysis of EQ-5D Data From Patients in the MOTION Trial
Sep 9, 2025, 16:22 PM -
From Unstructured Text to Enriched Data: Evaluating Large Language Models for Clinical Information Extraction From Echocardiogram Reports
Sep 9, 2025, 16:22 PM -
Economic Evaluations of First-Line Non-Small Cell Lung Cancer Therapies: A Systematic Review With Focus on PD-L1 Subgroups
Sep 9, 2025, 16:22 PM -
Development of Cardiovascular Risk Equations: Integrating Clinical Expertise With Data From the SELECT Trial
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Mixed-Approach Maternal RSVpreF/Infant Nirsevimab Immunization vs. Nirsevimab Alone for Prevention of Respiratory Syncytial Virus in Spain
Sep 9, 2025, 16:22 PM -
Synthetic Data Generation vs. Simulated Treatment Comparison: Assessment of the Performance of a Novel Approach for Unanchored Indirect Treatment Comparisons
Sep 9, 2025, 16:22 PM -
The Challenges of Evaluating Individualized Therapies in Health Technology Assessment: A Thematic Review
Sep 9, 2025, 16:22 PM -
Global Payer Policies Potentially Impacting Pharma Pricing and Market Access Strategies: A Review of Five Key Trends Shaping Pharma Future
Sep 9, 2025, 16:22 PM -
Transfusion Healthcare Resource Utilization and Associated Impact of Quality of Life Among Patients With Myelofibrosis and Anemia: A Multinational Real-World Survey
Sep 9, 2025, 16:22 PM -
Mapping of Treatment Patterns and Transfusion Status in Danish and Swedish Myelofibrosis (MF) Patients
Sep 9, 2025, 16:22 PM -
Effectiveness of Inclisiran and Evolocumab in LDL-C Goal Attainment: A Hybrid Decision Tree-Markov Model Analysis
Sep 9, 2025, 16:22 PM -
A Cross-Sectional Analysis of Early Access Programs in NICE Health Technology Assessments
Sep 9, 2025, 16:22 PM -
Incidence and Treatment of Squamous-Cell Anal Cancer (SCAC) in Germany: A Retrospective Study in German Statutory Health Insurance (SHI) Claims Data
Sep 9, 2025, 16:22 PM -
Evaluating AI Chatbot Empathy and Probing Skills in Automated Patient In-Trial Interviews: A Proof of Principle Experiment
Sep 9, 2025, 16:22 PM -
HTA Conflicts in Europe: Agreeing to Disagree?
Sep 9, 2025, 16:22 PM -
Assessing Patient Access to Psoriasis Treatments in Central, South, and Eastern European Countries: Insights and Disparities?
Sep 9, 2025, 16:22 PM -
Methodological Approach to Assess the Environmental Impact Analysis of Expanding Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in the Chronic Kidney Disease Patient Pathway: A French Perspective
Sep 9, 2025, 16:22 PM -
The Budget Impact and Time Savings of Introducing Subcutaneously Administered Nivolumab and Hyaluronidase (NIVO SC) to Patients Receiving Intravenously Administered Nivolumab (NIVO IV) Across Indications in Canada
Sep 9, 2025, 16:22 PM -
Use of EORTC Item Lists for Patient-Reported Outcome Measurement in Industry-Sponsored Research: A Three-Year Snapshot of Study Characteristics
Sep 9, 2025, 16:22 PM -
A Case Study: How England Implemented Its First Population Health Agreement
Sep 9, 2025, 16:22 PM
